
Aethlon Medical AEMD
$ 5.43
4.42%
Quarterly report 2025-Q2
added 08-13-2025
Aethlon Medical Gross Profit 2011-2025 | AEMD
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 M | 1.36 M | 1.36 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Dynatronics Corporation
DYNT
|
6.01 M | $ 0.24 | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
11.1 M | $ 1.48 | 1.37 % | $ 20.5 M | ||
|
Natus Medical Incorporated
NTUS
|
274 M | $ 31.08 | 1.94 % | $ 1.05 B | ||
|
Pulmonx Corporation
LUNG
|
62 M | $ 1.98 | 26.92 % | $ 77.4 M | ||
|
Medtronic PLC
MDT
|
19.6 B | $ 93.23 | -0.96 % | $ 120 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
584 K | $ 3.05 | -5.86 % | $ 30.6 M | ||
|
Cardiovascular Systems
CSII
|
173 M | $ 20.0 | 0.15 % | $ 844 M | ||
|
Neovasc
NVCN
|
1.99 M | $ 30.03 | - | $ 111 M | ||
|
Apollo Endosurgery
APEN
|
42.4 M | $ 10.0 | - | $ 475 M | ||
|
Viveve Medical
VIVE
|
620 K | $ 0.22 | -15.35 % | $ 1.71 M | ||
|
Invacare Corporation
IVC
|
48.3 M | $ 0.66 | - | $ 24.7 M | ||
|
Abiomed
ABMD
|
690 M | $ 381.02 | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
443 K | $ 0.55 | 3.58 % | $ 2.21 M | ||
|
Quanterix Corporation
QTRX
|
70.6 M | $ 5.48 | -3.52 % | $ 206 M | ||
|
AVITA Medical
RCEL
|
55.2 M | $ 3.66 | -3.43 % | $ 94.7 M | ||
|
CryoLife, Inc.
CRY
|
168 M | $ 17.84 | -4.14 % | $ 702 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | $ 24.04 | - | $ 1.77 B | ||
|
Sintx Technologies
SINT
|
1.84 M | $ 3.46 | -4.68 % | $ 12.9 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | $ 10.38 | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
28.7 M | $ 30.65 | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
43.7 M | $ 26.54 | - | $ 462 M | ||
|
ShockWave Medical
SWAV
|
635 M | $ 334.75 | - | $ 12.3 B | ||
|
SeaSpine Holdings Corporation
SPNE
|
115 M | $ 7.16 | 0.28 % | $ 270 M | ||
|
ViewRay
VRAY
|
10 M | $ 2.64 | 1.54 % | $ 468 M | ||
|
Intersect ENT, Inc.
XENT
|
50.2 M | $ 28.24 | - | $ 955 M | ||
|
Bruker Corporation
BRKR
|
1.65 B | $ 38.72 | 0.21 % | $ 5.77 K | ||
|
Axonics Modulation Technologies
AXNX
|
198 M | $ 70.98 | - | $ 3.31 B | ||
|
BIOLASE
BIOL
|
16.7 M | $ 0.13 | -13.19 % | $ 166 K | ||
|
Eargo
EAR
|
14.3 M | $ 2.57 | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
31 M | $ 10.15 | 1.6 % | $ 289 M | ||
|
Viemed Healthcare
VMD
|
113 M | $ 6.86 | -1.29 % | $ 263 M | ||
|
SmileDirectClub
SDC
|
328 M | $ 0.08 | -53.45 % | $ 9.71 M | ||
|
Globus Medical
GMED
|
719 M | $ 62.75 | -0.77 % | $ 8.52 B | ||
|
ThermoGenesis Holdings
THMO
|
2.71 M | $ 0.31 | -25.84 % | $ 171 K | ||
|
Acutus Medical
AFIB
|
-3.14 M | $ 0.09 | -26.83 % | $ 2.62 M | ||
|
ClearPoint Neuro
CLPT
|
19.1 M | $ 26.98 | 5.97 % | $ 729 M | ||
|
Surgalign Holdings
SRGA
|
40.3 M | $ 0.18 | -32.98 % | $ 1.68 M | ||
|
Conformis
CFMS
|
23.2 M | $ 2.27 | - | $ 16.4 M | ||
|
Sientra
SIEN
|
44.3 M | $ 0.18 | -16.59 % | $ 10.3 M | ||
|
NuVasive
NUVA
|
865 M | $ 39.75 | - | $ 2.07 B | ||
|
Cutera
CUTR
|
-12.7 M | $ 0.1 | -10.19 % | $ 1.99 M | ||
|
Nemaura Medical
NMRD
|
-1.48 M | $ 0.11 | -17.8 % | $ 2.74 M | ||
|
Vapotherm
VAPO
|
28.3 M | $ 1.27 | 6.72 % | $ 34 M | ||
|
Beyond Air
XAIR
|
-1.66 M | $ 2.1 | 0.96 % | $ 142 M | ||
|
FONAR Corporation
FONR
|
42.4 M | $ 15.39 | 0.39 % | $ 101 M | ||
|
Talis Biomedical Corporation
TLIS
|
10.9 M | $ 4.38 | 3.55 % | $ 7.96 M |